Objectives: Objectives were, first, to estimate the additional number of quality-adjusted life years (QALYs) gained by deaf children from bilateral compared with unilateral implantation (⌬Q); second, to estimate the additional cost to the healthcare system in the United Kingdom for providing bilateral compared with unilateral implantation (⌬C); and, third, to compare the values of incremental net benefit (INB), r⌬Q Ϫ ⌬C, with criteria used by policy makers in deciding whether to adopt health technologies. In England and Wales, the healthcare policy-making body must be satisfied that the INB is positive for a maximum value of r of £30,000 (the "net-benefit" criterion). Policy makers may also require the likelihood that the technology is cost-effective to exceed 0.8 (the "likelihood" criterion).
INTRODUCTION
This article reports estimates of the cost-effectiveness of providing bilateral cochlear implants to young deaf children. Although the cost data are specific to the healthcare system in the United Kingdom, the estimates of benefit and the methods for relating costs and benefits to decision criteria are relevant to all healthcare systems.
In many countries, healthcare policy makers have struggled to decide whether deaf children should receive bilateral or unilateral cochlear implants. In England and Wales, for example, the policy-making body, the National Institute for Health and Clinical Excellence (NICE), first published draft guidance that recommended bilateral implantation for newly diagnosed young deaf children but not for children who already possessed one implant (NICE 2007) . A second draft guidance excluded bilateral implantation for the majority of deaf children, except in the context of research (NICE 2008a) . The final guidance (NICE 2009 ), which determines policy in the health service in England and Wales, recommends bilateral implantation for newly diagnosed young deaf children and allows a second implant for some children who already have one implant.
NICE requires evidence that health technologies are safe, clinically effective, and cost-effective before they are adopted. Decision making about bilateral implantation for children was hampered by the absence of data on the additional quality of life associated with using two implants compared with one. These data are required to estimate the cost-effectiveness of bilateral implantation; that is, to determine whether the incremental benefit from two implants rather than one justifies the incremental cost of providing and maintaining two implants rather than one. In this article, we first report estimates of the incremental gain in quality of life associated with bilateral implantation compared with unilateral implantation for children. The estimates were cited in the NICE Guidance (NICE 2009 ). We then combine those data with estimates of the incremental cost of providing and maintaining bilateral implants to estimate the incremental cost-effectiveness of bilateral implantation for children.
Generic Measures of Health-Related Quality of Life
Policy makers require evidence of the impact of conditions on patients, and of the effectiveness of interventions for those conditions, on scales that are generic and hence are applicable to all conditions and all interventions. The standard measure in this domain is the health utility of a patient, sometimes also called health-related quality of life. Health utility takes a value on a scale where 1 corresponds to perfect health and 0 to death. There are two formal methods for estimating health utility (Drummond et al. 1997) . The time trade-off (TTO) requires respondents to estimate the number (n) of years in perfect health that would be equivalent to living their expected Department remaining years of life (e) in their current state of ill health. The respondent's health utility is calculated as n/e. The standard gamble requires respondents to balance two hypothetical alternatives: living in their current state of ill health for the remainder of their expected years of life or taking a gamble that could cure them with probability (p) or kill them with probability (1 Ϫ p) . Respondents adjust the value of p until they are indifferent between the two alternatives, at which point their health utility is given by the value of p.
In many clinical situations, questionnaires are used as surrogates for the formal methods. The questionnaire defines a set of dimensions on which good function is considered to correspond to good health. Levels of function on each dimension are also defined. Members of the public are asked to value the states of health defined by a subset of all combinations of the levels using one of the formal methods. Statistical modeling is used to deduce a scoring algorithm that converts any combination of the levels into the average value of health utility that would be given to the combination by members of the public. Then, the scoring algorithm, together with a questionnaire that establishes a patient's level of function on each dimension, can be used to estimate the patient's heath utility in accordance with public preferences for better and poorer health. The Health Utilities Index Mark 3 (HUI3; Feeny et al. 2002) and the EuroQol Descriptive System (EQ5D; Brooks et al. 2003) are the two widely used questionnairebased systems of this sort. They may be preferred over the direct methods when patients themselves are unable or unwilling to use the direct methods or if policy makers want health status to be valued in accordance with public, rather than patient, preferences.
Challenges in Estimating the Health Utility of Young Deaf Children
Several challenges arise in estimating the health utility of young children who receive an intervention that may improve hearing. First, the formal methods and the questionnaires are conceptually demanding and could not be used with the majority of young deaf children themselves. The proxy judgments of parents and carers can be obtained instead. However, although the parents of deaf children have completed the HUI3 on their children's behalf (Cheng et al. 2000; Barton et al. 2006c; Lovett et al. 2010) , only a subset of parents have been willing to participate in exercises where they trade off years of their own lives to value their deaf child's quality of life (Cheng et al. 2000) . No study has attempted to use the standard gamble to elicit estimates of the quality of life of deaf children.
The second challenge arises because the questionnairebased systems are not recommended for use with children as young as 1 to 3 years, which is the usual age range at the time of cochlear implantation of congenitally deaf children in the UK. The third challenge arises because hearing loss is rarely the consequence of disease and is not usually perceived to be a manifestation of ill health. As a result, the parents of deaf children associate deafness with a loss of general quality of life rather than health-related quality of life (Sach & Barton 2007) , and the EQ5D, with its emphasis on health, is not strongly responsive to impaired hearing nor to interventions that improve hearing (Grutters et al. 2007 ). The HUI3, in comparison, is responsive to impaired hearing (Grutters et al. 2007 ) and to unilateral cochlear implantation (Cheng et al. 2000 ; UK Co-chlear Implant Study Group 2004; Barton et al. 2006c ), but the scoring algorithm is based on preferences for better and poorer health of citizens of Canada rather than citizens of the UK. Healthcare policy makers prefer to base policy on estimates of cost-effectiveness that reflect the preferences of their native population.
Previous Estimates of the Incremental Gain in Quality of Life Associated With Bilateral Implantation
Five studies are relevant. Summerfield et al. (2002) created vignettes describing adults with unilateral and bilateral implants. The vignettes were presented to 70 adult informants with a professional knowledge of hearing and deafness. They imagined that the description applied to them and valued it using the TTO technique. The mean value assigned to the state of having a unilateral implant was 0.934 (95% confidence interval [CI] 0.915 to 0.954) and to the state of having a bilateral implant was 0.964 (95% CI 0.952 to 0.978). The increment in health utility, ϩ0.031, was small but significant (95% CI 0.018 to 0.042). Summerfield et al. (2006) administered the HUI3 to 24 adults who were users of a single implant 1 month before, and 3 and 9 months after, they received a second implant. The mean change in health utility was Ϫ0.026 (95% CI Ϫ0.122 to ϩ0.070) at 3 months and Ϫ0.015 (95% CI Ϫ0.108 to ϩ0.078) at 9 months. The nonsignificant declines in utility were attributed to a minority of the participants who experienced exacerbated tinnitus on receipt of a second implant. The overall change at 9 months was decomposed statistically into a negative component associated with worsened tinnitus and a positive, but nonsignificant, component associated with improved hearing. The positive component was ϩ0.030 (95% CI Ϫ0.045 to ϩ0.104). Lovett et al. (2010) obtained estimates of the quality of life of 30 children with bilateral implants and 20 children with unilateral implants. The childrens' parents valued their child's quality of life on a 100-point visual analog scale (VAS) whose endpoints were labeled "Best" and "Worst" imaginable quality of life. VAS ratings were divided by 100 to yield values in the 0 to 1 range. Parents also completed the HUI3. The mean values estimated by parents of unilaterally implanted children were 0.85 (95% CI 0.79 to 0.90) using the VAS and 0.72 (95% CI 0.60 to 0.81) using the HUI3. The mean values estimated by parents of bilaterally implanted children were 0.89 (95% CI 0.84 to 0.93) using the VAS and 0.72 (95% CI 0.63 to 0.79) using the HUI3. Neither difference between the unilaterally and bilaterally implanted groups was significant: VAS, ϩ0.04 (95% CI Ϫ0.04 to ϩ0.12); HUI, Ϫ0.003 (95% CI Ϫ0.15 to ϩ0.14).
These nonsignificant differences contrast with significant differences in the VAS valuations of parents of bilaterally implanted children who were asked to value the quality of life of their child while imagining that he or she had not received a second implant (0.56, 95% CI 0.49 to 0.63), giving an incremental difference of ϩ0.33 (95% CI ϩ0.25 to ϩ0.40) (Reference Note 1). Significant differences between retrospective judgments of health utility with one implant and contemporary judgments with two implants were reported by Bichey and Miyamoto (2008) who administered the HUI3 to a heterogeneous group of 23 adult and child patients.
The relevance of the first two datasets (Summerfield et al. 2002 (Summerfield et al. , 2006 is limited because they concern adults rather than children. Limitations of the third dataset (Lovett et al. 2010) are that judgments by parents may be biased by a reluctance to value their own child's quality of life as other than near perfect and by gratitude for healthcare received or paid for. Limitations of the fourth and fifth datasets (Reference Note 1; Bichey & Miyamoto 2008) are that retrospective judgments of quality of life may be biased by errors of recall and may confound effects of treatment with effects due to other events including maturation. For these reasons, we took a different approach to estimate the incremental benefit of bilateral over unilateral implantation for children. We first implemented that approach and then incorporated its results in analyses of cost-effectiveness.
MATERIALS AND METHODS

Estimating the Incremental Benefit of Bilateral Over
Unilateral Implantation for Children Questionnaires • A questionnaire (Appendix) was compiled incorporating four vignettes. Each vignette described the everyday functioning and future prospects of a hypothetical female child who had been born bilaterally profoundly deaf and who was now 6 years old. The first vignette stated that the child had not received any assistive device to aid her hearing (No-CI). The second vignette envisaged that the child had received a unilateral cochlear implant at the age of 2 years (One-CI). The third vignette envisaged that the child had received a unilateral implant at the age of 2 years and had enough residual hearing in the nonimplanted ear to benefit a little from acoustic amplification in that ear (CI ϩ HA). The fourth vignette envisaged that the child had received bilateral cochlear implants at the age of 2 years (CI ϩ CI). Each vignette described a child who was an uncomplicated case and who was achieving outcomes that were average for children with whatever combination of assistive devices, or none, she was envisaged to be using.
The construction of the vignettes was guided by evidence from six domains: (1) studies of outcomes for deaf children (Barton et al. 2006a,b; Stacey et al. 2006 ); (2) the experience of the first and second authors in conducting research with implanted children; (3) issues highlighted in research reports of the listening skills of children with unilateral and bilateral cochlear implants (Litovsky et al. 2006; Ching et al. 2007 ); (4) issues highlighted in research reports of data obtained with parent-proxy questionnaires that seek judgments of outcomes for children with implants (Hinderlink et al. 2000; Galvin et al. 2007 ); (5) issues reported to be relevant to the parents of hearing-impaired children (Sach & Whynes 2005) ; and (6) discussion boards on the websites of charities that support children with impaired hearing and their families.
In the preamble to the questionnaire, respondents were asked to imagine that they were the parent of the child described in each vignette. They were 33 years old and could expect to live for another 50 years. These values were chosen to be close approximations to population statistics (Reference Notes 2 and 3) while being convenient numbers with which to work. Respondents were instructed to read the whole questionnaire and then to value the quality of life of each hypothetical child first using a VAS and then using the TTO technique as described in the Appendix.
Respondents • Respondents were sampled opportunistically from three populations chosen to span a range of age and experience: clinicians/researchers, undergraduate students, and members of the public. The clinicians/researchers worked on aspects of child health, including childhood deafness. They attended lectures on cochlear implantation where they were given a questionnaire that they returned if they elected to participate. The students were enrolled in British universities. They were invited to participate by e-mail and attended an appointment to complete the questionnaire. The parents were sampled from the membership of a charity that supports parents of children with special needs. A questionnaire was mailed to them, which they returned if they elected to participate. Approximately half of the members of this group were the parents of a disabled child. None were the parents of a child with impaired hearing. These methods were approved by the Research Ethics Committee of the Department of Psychology of the University of York.
Conversion of Valuations to Estimates of Health Utility
• Years given up (x) in the TTO procedure were converted to health utilities (U TTO ) with the following equation:
VAS values (V) were converted to health utilities (U VAS ) with a compressive transform: 1.6 (2)
Compression compensates for the fact that VAS valuations do not reflect the risk aversion and opportunity cost that are components of formal measures of health utility. Equation (2) has previously brought VAS values into approximate concordance with TTO utilities (Cheng et al. 2000) . The equation has a similar effect to the function, U ϭ (V/100) 0.47 , used by Feeny et al. (2002) to bring VAS valuations into correspondence with standard gamble utilities.
Analyses of Cost-Effectiveness
Decision Problem • The decision problem faced by policy makers is whether a child born with a severe-profound bilateral hearing loss should receive a unilateral cochlear implant, with the option of an acoustic hearing aid for the nonimplanted ear, or should receive bilateral cochlear implants. To address that problem, the incremental cost of providing two implants rather than one was compared with the incremental benefit of providing two implants rather than one. The incremental cost was estimated as the lifetime cost to the National Health Service in the UK for providing and maintaining two implants rather than one. The incremental benefit was estimated as the additional number of quality-adjusted life years (QALYs) gained over a child's lifetime from using two implants rather than one. The incremental QALYs were calculated from the respondents' estimates of the additional health utility associated with bilateral implantation compared with unilateral implantation.
Unilateral Implantation • We also undertook an analysis of the cost-effectiveness of unilateral implantation compared with nonsurgical intervention. Unilateral implantation has been judged to be a cost-effective intervention for children when the increment in health utility is assessed by parents/carers using the HUI3 (Cheng et al. 2000; Barton et al. 2006c; Bond et al. 2007 ). If the incremental gain in utility estimated for unilateral SUMMERFIELD ET AL. / EAR & HEARING, VOL. 31, NO. 5, [611] [612] [613] [614] [615] [616] [617] [618] [619] [620] [621] [622] [623] [624] implantation by the present respondents were not consistent with previous estimates then doubt would be cast on the plausibility of the respondents' estimates of the incremental gain in utility for bilateral implantation.
Decision-analytic Modeling • A probabilistic decision-ana-
lytic model ) was constructed to address the decision problem. The aim was to bring together data on the incremental costs of implantation with data on the associated incremental benefits in a framework that expresses the uncertainty in the estimates of both increments resulting from random variation, lack of knowledge, and measurement error. The model estimates the conjoint distribution of incremental costs and incremental QALYs to inform judgments of costeffectiveness.
The model is illustrated in Figure 1 . It describes events that could occur to a child in each year of care after referral for implantation. A probability of occurrence and an incremental cost are associated with each event in each year of care. When the model was applied to bilateral implantation, the cost parameters were estimates of the incremental cost of providing bilateral rather than unilateral implantation. When the model was applied to unilateral implantation, the cost parameters were estimates of the incremental cost of providing unilateral implantation compared with nonsurgical intervention. The model incorporates the probabilities and costs estimated by Bond et al. (2007) in synthesizing a decision-analytic model of cochlear implantation for NICE. General parameters of the model are listed in Table 1 . Probability parameters are listed in Table 2 . Cost parameters are listed in Table 3 .
The model considers that children are referred during their second year of life, undergo assessment, and are then implanted immediately before their second birthday with either one implant or with two implants in a single surgical session. These events occur during the 0th year of care.
Events in the first and subsequent years of care are of three sorts. (1) Some events occur with a probability of unity: tuning implant systems, providing therapeutic habilitation, maintaining implant systems, and upgrading the external parts of implant systems. (2) A second sort of event occurs with a probability less than unity: replacement of failed external or internal components of an implant system and management of other medical-surgical complications. The model allows up to one instance of each of these events to occur in each year of care. (3) Other events terminate the use of an implant system: Probability Parameters • Estimates of probabilities (Table 2) were taken from Bond et al. (2007) with two exceptions. Bond et al. combined data from three manufacturers of cochlear implants to derive a function characterizing the cumulative survival of the internal components of implant systems in children. The resulting plot of cumulative survival against time fell at a rate that reduced over time and that reached 90% survival after approximately 36 years (Bond et al. 2007, Fig. 8, p. 201) . We approximated this curve by modeling the probability of internal failure in the Nth year of care as (0.003 ϩ 0.000001 [100 Ϫ N]). The second departure from the model of Bond et al. concerned voluntary nonuse of a functioning implant system. Bond et al. considered that voluntary nonuse occurred at the start of the third year of care (i.e., after a 2-year trial period with an implant), and that use either ceased at that point or continued until death. The probability of nonuse was obtained from Ray et al. (2004) and was 0.0236. It was applied to all children. We modified that rule to reflect data from adults, which show that the main risk factor for voluntary nonuse of implants is low benefit (Summerfield & Marshall 2000) . Accordingly, the probability of voluntary nonuse was set to a non-zero value if the incremental benefit was smaller than a criterion; otherwise, the probability of voluntary nonuse was set to zero. The criterion and the non-zero probability were adjusted so that an overall proportion of 0.0236 of children were modeled as voluntary nonusers.
Cost Parameters • Estimates of costs (Table 3) Costs of the internal and external components of implant systems were considered to be fixed because they are determined by national contracts in the UK. Other costs are less predictable. The average cost of managing each event had been derived originally from top-down analyses in which the budgets of cochlear implant programs were apportioned among the number of patients whom they managed (Barton et al. 2003 (Barton et al. , 2006c UK Cochlear Implant Study Group 2004) . In practice, some patients require more management than others and therefore the cost of most events varies among patients and is unpredictable. That uncertainty was captured by drawing randomly from distributions of costs associated with each event. Costs are greater than zero and are often positively skewed. Accordingly, following Briggs et al. (2006) , the distributions of costs were described by gamma functions. The variance of each function was set to one-fifth of its mean value. Table 3 shows that Bond et al. (2007) considered that the costs of tuning and maintaining bilateral and unilateral implants were the same. We assessed the sensitivity of conclusions to this assumption.
Use of Hearing Aids
• We adopted the same assumptions about the use of hearing aids as were made by Bond et al. (2007) . The cost to the health service in the UK for providing a digital hearing aid to a child is £100. Hearing aids are replaced every 5 years. All children are fitted with bilateral hearing aids as part of the process of assessment for implantation. In the absence of implantation, 50% of children would continue to use two hearing aids while 50% would use only one hearing aid. After unilateral implantation, 80% of children use an acoustic hearing aid in the nonimplanted ear. After bilateral implantation, no hearing aids are used. In estimating the incremental cost of unilateral implantation, the cost of hearing aids that would have been used in the absence of implantation were averted, whereas the cost of maintaining a hearing aid in 80% of nonimplanted ears was included. In estimating the incremental cost of bilateral implantation, the cost of maintaining hearing aids that would have been used in the absence of bilateral implantation was averted.
Incremental Gains in Utility • The incremental gains in utility calculated from the valuations of the 180 informants were used to describe the distribution of gains that would be received by children undergoing implantation. To reflect the proportion of unilaterally implanted children who use a hearing aid, a value of the incremental gain was estimated by sampling randomly with replacement from the distributions of increments involving CI ϩ HA on 80% of simulations and from the distributions of increments involving CI-only on 20% of simulations.
It was assumed that a proportion 0.28 of the gain would be realized in the first and second years of care and a proportion 0.91 would be realized in the third and fourth years of care. It was assumed that the full gain would be realized thereafter. This pattern of increasing gain with time after implantation was found for unilateral implantation (Barton et al. 2006c ). The idea that the full gain would be realized from the start of the fifth year of care, when the child would be aged 6 years, is compatible with the fact that the informants judged the quality of life of the child at the age of 6 years.
Primary and Secondary Analyses • The TTO technique
gives direct estimates of utility while VAS yields indirect estimates that must be compressed to provide plausible estimates. The results of analyses based on VAS values depend on the degree of compression that is applied to the valuations and therefore have an arbitrary aspect. For that reason, primary analyses combined the parameters in Tables 3-5 with values of   TABLE 3 
. Incremental cost parameters of the decision-analytic model in pounds sterling (£) at 2007 cost levels
Event
Year of Care All parameters were sourced from Bond et al. (2007) . n/a, not applicable. Sensitivity Analyses • The sensitivity of conclusions to assumptions about two cost parameters was explored. Analyses of bilateral implantation were run with the cost of tuning and maintenance increased by 25% and, separately, by 50% of the base values in Table 3 , and with the cost of the second set of internal components reduced by 40% from its base value (i.e., from £10,547 to £6,328). In these analyses, the cost of the external components was not changed from its base value nor was the cost of replacing the second implant changed from its base value if the implant failed outside its 10-year warranty period.
Analyses for Individual Groups • To test the sensitivity of conclusions to the composition of the group of informants, additional analyses were run with the data of each group individually.
Discounting • Future costs and future benefits were discounted in line with recommendations by the UK Treasury and in accordance with the principle of time preference; i.e., that people, on average, give higher value to benefits gained sooner rather than later but prefer to incur expenditure later rather than sooner. The discount rate for costs and benefits was 3.5% per annum, meaning that the incremental cost, ⌬C, was aggregated as:
where i is the number of the year of care, n is the last year of care in which services are provided, and c i is the total incremental cost incurred in the ith year of care. Note that costs incurred in the 0th year of care were not discounted. The total incremental QALYs, ⌬Q, were aggregated as:
where i and n have the same meanings as in Eq. (5), u is the increment in utility, and w i are weights reflecting the increasing gain in utility with time after implantation. Note that benefits were judged not to occur until the end of the first year of care and were discounted. To show how these values vary as a function of the WTP threshold, net benefit was calculated for values of r ranging from 0 to £100,000. For each value of r, two further values were calculated: (1) the average INB and its 95% confidence interval; and (2) the proportion of simulations for which the INB was greater than 0; this value estimates the likelihood that intervention X is cost-effective.
Analyses
Assessment Criteria • Decisions on adoption are guided principally by whether the value of the QALYs gained from an intervention exceeds the cost of gaining them; that is, by whether the average INB is positive (Fenwick et al. 2001) . NICE requires its appraisal committees to "identify an increasingly stronger case for supporting a technology" (NICE 2008b, p. 59 ) if more than £30,000 has to be spent to gain a QALY. Accordingly, the WTP threshold in England and Wales is taken as £30,000/QALY. However, the average INB may be positive at this threshold but with wide confidence intervals. For that reason, policy makers may also wish to know the likelihood that an intervention is cost-effective. They may require a high likelihood where the intervention has a large impact on the cost of health care resulting from a high incremental cost, a large number of recipients, or both. Policy makers may accept a lower likelihood where the impact is smaller, as it is for cochlear implantation. Values of 0.99 and 0.80 for the higher and lower likelihoods have been proposed (Willand & Briggs 2006) .
Because the net-benefit and likelihood criteria are interrelated, we assessed the evidence for cost-effectiveness in terms of both of them. We judged that an intervention is probably cost-effective if the average INB is positive at a WTP threshold of £30,000/QALY and the likelihood that the intervention is cost-effective if it exceeds 0.8. We judged that an intervention is possibly cost-effective if the average INB is positive at a WTP threshold of £30,000/QALY but the likelihood that the intervention is cost-effective is Ͻ0.8.
Presentation of Results
• Results of primary and secondary analyses are presented graphically in three formats: (1) as scatter plots on the cost-effectiveness plane (i.e., plots of ⌬Q versus ⌬C; Black 1990); (2) 
RESULTS
Estimating the Incremental Benefit of Bilateral Over Unilateral Implantation for Children Response Rates and Missing Data • Questionnaires were
returned by 34 of 142 clinicians/researchers (24%), 83 of 108 students (77%), and 72 of 106 parents (68%). Data were missing from questionnaires returned by two clinicians/researchers, one student, and six parents. These respondents were excluded. Biographical characteristics of the 180 respondents who provided complete data are given in Table 4 .
Increments in Utility • Four incremental differences in
health utility were calculated: (1) One-CI Ϫ No-CI, (2) CI ϩ HA Ϫ No-CI, (3) CI ϩ CI Ϫ One-CI, and (4) CI ϩ CI Ϫ CI ϩ HA. Their distributions were skewed with the mean greater than the median (Table 5 ). Wilcoxon signed rank tests were used to assess whether the incremental differences were statistically significant and whether the U VAS values differed from the U TTO values. The incremental differences were all positive and significant (z Ͼ8.9, p Ͻ 0.001). Differences estimated from values of U VAS were generally larger than differences estimated from values of U TTO , with the exception of the difference between CI ϩ HA and CI ϩ CI: (1) One-CI Ϫ No-CI, z ϭ 6.49, p Ͻ 0.001; (2) CI ϩ HA Ϫ No-CI, z ϭ 6.29, p Ͻ 0.001; (3) CI ϩ CI Ϫ One-CI, z ϭ 2.57, p Ͻ 0.01; (4) CI ϩ CI Ϫ CI ϩ HA, z ϭ 1.93, p Ͼ 0.05.
For the comparisons of one implant with no implant, clinicians/researchers estimated larger increments than parents, with students in between. For the comparisons of one implant with two implants, clinicians/researchers estimated smaller values of the increments than parents, with students in between. These differences in median values between groups were assessed with Kruskal-Wallis one-way analyses of variance. With the TTO utilities, the increment from No-CI to One-CI differed significantly between groups ( 2 ϭ 2, df ϭ 2, p Ͻ 0.05). With the VAS utilities, the increment from One-CI to CI ϩ CI differed significantly between groups ( 2 ϭ 7.3, df ϭ 2, p Ͻ 0.05). None of the other six increments differed significantly between groups.
Interim Discussion
• Adults, who were not themselves the parents of deaf children, gave a significantly higher average value to the quality of life of a typical child with two implants compared with one implant. There were differences between the groups, which can be summarized with the statement that clinicians/researchers judged that unilateral implantation con-tributed 66% (U TTO ) and 68% (U VAS ) of the total gain from no implant to two implants, whereas the percentages judged by parents were smaller: 41% (U TTO ) and 43% (U VAS ). Nonetheless, the differences between groups were considered to be small in relation to the sizes of the increments. Accordingly, we used these data to inform analyses of the cost-effectiveness of bilateral compared with unilateral implantation. In the main analyses, the data of the three groups were pooled. We conducted supplementary analyses to test the sensitivity of conclusions to the pooling of data.
Analyses of Cost-effectiveness Primary Comparison of Bilateral With Unilateral Implantation • The conjoint distribution of incremental costs
and incremental QALYs resulting from the primary comparison of bilateral implantation with unilateral implantation, based on values of U TTO , is plotted in Figure 2A . Incremental costs range from Ͻ£20,000 to nearly £60,000, depending on the length of time for which implants are used and on the number of adverse events that occur. Incremental QALYs range from negative values, resulting from negative estimates of the incremental gain in health utility provided by three informants, to Ͼ15 QALYs. Vertical striations in the clusters of points result from the tendency of informants to trade off numbers of years that were multiples of 10.
The average INB of the 3000 comparisons of bilateral implantation with unilateral implantation is plotted as a function of the WTP threshold by the sloping continuous line in Figure 3A . Average INB is positive provided that more than £21,768 is spent to gain a QALY. Thus, the analysis indicates that bilateral implantation is cost-effective in relation to a WTP threshold of £30,000/QALY. The uncertainty surrounding that conclusion is shown in two ways. First, the 95% confidence limits of the average INB, plotted as the dashed lines in Figure 3A , are broad. Second, the probability that bilateral implantation is cost-effective is low. This point can be seen by reverting to Figure 2A in which the slanting line has a slope of £30,000/QALY. Simulations to the right of this line are individually cost-effective if commissioners are able to pay £30,000 to gain a QALY. The proportion of simulations that are individually cost-effective provides an estimate of the likelihood that bilateral implantation is costeffective. That likelihood is plotted as a function of the slope of the line (i.e., as a function of the WTP threshold) by the continuous line in Figure 4A . At a WTP threshold of £30,000/ QALY, bilateral implantation has a likelihood of 0.480 being cost-effective. The likelihood exceeds 0.5 if the WTP threshold is increased to £31,695. The likelihood does not exceed 0.8 for any value of the WTP threshold. Figures 2B, 3B, and 4B show the results of the secondary comparison of bilateral implantation with unilateral implantation. Herein, estimates of the incremental gain in health utility were based on values of U VAS , which were larger than the corresponding values of U TTO ( Table 2) . As a consequence, the results are more favorable to the conclusion that bilateral implantation is cost-effective. The average net benefit is positive provided that Ͼ£18,173 is spent to gain a QALY, although the confidence interval around that value remains large (Fig. 3B) . The likelihood that bilateral implantation is cost-effective exceeds 0.5 at a WTP threshold of £30,000 but exceeds 0.8 only if the threshold is increased to £80,000 (Fig. 4B ). • Figures 2C, 3C , and 4C plot results of the comparison of unilateral implantation with nonsurgical intervention based on values of U TTO . The average net benefit is positive provided that Ͼ£19,861 is spent to gain a QALY. Unilateral implantation has a likelihood of 0.604 being cost-effective at a WTP threshold of £30,000/QALY, but the likelihood does not exceed 0.8 at any value of the threshold. Figures 2D, 3D , and 4D plot corresponding results based on values of U VAS . The average net benefit is positive provided that Ͼ£12,049 is spent to gain a QALY. At a WTP threshold of £30,000/QALY, unilateral implantation has a probability of 0.768 being cost-effective, increasing to 0.8 at a threshold of £32,000. Therefore, comparisons of unilateral implantation with nonsurgical intervention generated greater INB and a higher likelihood of being cost-effective than comparisons of bilateral implantation with unilateral implantation. These differences are compatible with the behavior of healthcare commissioners who have been more confident that unilateral than bilateral implantation is a cost-effective use of resources.
Secondary Comparison of Bilateral With Unilateral Implantation •
Unilateral Implantation
Sensitivity Analyses • If policy makers were provided only
with the results of the primary analysis of bilateral versus unilateral implantation (Figures 2A, 3A , and 4A and row 1 of Table 6 ), the decision whether to adopt bilateral implantation would be finely balanced. The likelihood of adoption would be increased by the results of the secondary analyses in which U VAS replaced U TTO (Figures 2B, 3B and 4B and row 1 of Table 7 ) and by considering the consequences of reducing the cost of the second implanted device by 40% (row 3 of Tables 6 and 7). The likelihood of adoption would be reduced by considering the results of increasing the costs of tuning bilateral implants (rows 4 and 5 of Tables 6 and 7). Fig. 4 . Cost-effectiveness acceptability curves. In Panels A and B, continuous lines plot the likelihood that bilateral implantation is cost-effective in comparison with unilateral implantation as a function of the WTP threshold; dashed lines plot the likelihood that unilateral implantation is costeffective in comparison with bilateral implantation. In Panels C and D, continuous lines plot the likelihood that unilateral implantation is costeffective in comparison with nonsurgical intervention as a function of the WTP threshold; dashed lines plot the likelihood that nonsurgical intervention is cost-effective in comparison with unilateral implantation. Analyses in Panels A and C were based on U TTO . Analyses in Panels B and D were based on U VAS . WTP, willingness to pay.
Analyses for Individual Groups • Results of analyses based
on TTO and VAS estimates of health utility from each group of informants individually are summarized in Table 8 . In each analysis, the average INB is positive if £30,000 is spent to gain a QALY. The INB of unilateral implantation declines from clinicians/researchers to students to parents. The INB of bilateral implantation shows the complementary pattern.
DISCUSSION
The data and analyses reported in this article indicate that bilateral cochlear implantation of young congenitally deaf children is possibly a cost-effective use of resources in the health service in England and Wales. Adults who were not the parents of deaf children judged the quality of life of a hypothetical child who benefits from bilateral cochlear implants to be significantly higher than the quality of life of a similar child who benefits from a unilateral implant. If a QALY is valued at £30,000 -the highest amount that is routinely paid to gain a QALY in England and Wales-then estimates of the value of the additional QALYs, which the informants associated with bilateral implantation, exceed estimates of the additional costs that would be incurred in providing bilateral implants.
In synthesizing a decision-analytic model of bilateral implantation of children, Bond et al. (2007) based analyses on the assumption that the incremental gain in health utility for bilateral compared with unilateral implantation is ϩ0.03 (Summerfield et al. 2002 (Summerfield et al. , 2006 . Average INB was positive only if Ͼ£40,000 could be spent to gain a QALY. For the average INB to be positive at a WTP threshold of £30,000, it was necessary to assume that the incremental gain in health utility exceeded ϩ0.04. NICE judged that an increment greater than ϩ0.04 was plausible (NICE 2009 ). The valuations of the 180 informants in this study yielded mean increments of ϩ0.062 (based on U TTO ) and ϩ0.074 (based on U VAS ) and are therefore compatible with the assumptions of NICE.
Nonetheless, the distributions of increments in quality of life among the informants are broad and skewed (Table 5 ). The TTO data of up to one-third of informants yielded increments that were negative or zero, whereas the data of others yielded increments ranging up to ϩ0.60. That wide range reflects inconsistency between the judgments of informants and translates into low estimates of the likelihood that bilateral implantation is cost-effective. Thus, although the balance of probabilities favors the conclusion that bilateral implantation of young deaf children is a cost-effective intervention, the evi- ⌬U, average increment in U TTO ; ⌬Q, average increment in QALYs; ⌬C, average increment in costs; r, WTP threshold at which net benefit from the second intervention is positive; p, probability that second intervention is cost-effective at WTP threshold of £30,000. dence is not clear cut. Moreover, the methods that we used for assessing incremental costs and incremental benefits can be criticized. Therefore, the question arises whether the present evidence should inform healthcare decision making. We address that question by assessing the strengths and weaknesses of our methodology.
Limitations of the Methods for Estimating Benefit
Our sampling of informants and our use of vignettes both had limitations. First, the group of informants was an aggregate of three convenience samples, each of which gave similar, but not identical, valuations. Analyses based on a different blend of the three groups, or on a sample more representative of the population, might have prompted different conclusions. This criticism can be countered by noting that the data of each subgroup individually yielded positive net benefit for both unilateral and bilateral implantation (Table 8) . Thus, sufficient additional value is perceived by groups of informants differing widely in age and life experience, and by any weighted combination of the three groups, for both unilateral implantation and bilateral implantation to yield positive net benefit. That finding, in turn, makes it more, rather than less, likely that the valuations of a population-representative group would also yield positive net benefit.
The second limitation is that there is no a priori guarantee that the vignettes are accurate in their descriptions of children achieving typical outcomes. Higher or lower increments in utility might have been estimated with different vignettes. A defense against this criticism can be mustered by comparing previous and current estimates of the increment in health utility associated with unilateral implantation. Barton et al. (2006c) measured that increment using a version of the HUI3 by comparing children with unilateral implants and nonimplanted children, while controlling statistically for confounding differences between the groups. The group of children considered by Barton et al. who correspond most closely to the children described in the vignettes was composed of children implanted before the age of 5 years who had used their implants for at least 4 years (Barton et al., Table 1 ). The gain in health utility associated with unilateral implantation for that group was ϩ0.232 (95% CI 0.184 to 0.280; Barton et al., Table 3 ). This value exceeds the corresponding increment estimated with the TTO, which was ϩ0.145 (Table 6 , row 2). However, the value is very close to the increment estimated with the VAS, which was ϩ0.237 (Table 7, row 2) . This correspondence gives credibility to the VAS estimate of the increment in utility between bilateral and unilateral implantation, which was ϩ0.076 (Table 7 , row 1), despite any limitations in the sample of informants or the formulation of the vignettes.
Limitations of the Methods for Estimating Costs
No study has measured the costs associated with providing bilateral implants to children. The decision model incorporates cost parameters estimated by Bond et al. (2007) . Their cost parameters were derived from estimates of the costs of providing unilateral implantation, modulated by informed judgment of emerging practice in providing bilateral implantation. Some of those assumptions have face validity; for example, that surgery to implant two implants costs 50% more than surgery to implant one implant. Other assumptions seem less plausible; for example, that the costs of tuning bilateral implants are the same as the costs of tuning a unilateral implant. Nonetheless, the conclusion that bilateral implantation is possibly a costeffective use of resources is robust over an increase in the cost of tuning of 25% (for analyses based on U TTO , Table 6 , row 4) and of 50% (for analyses based on U VAS , Table 7 , row 6).
Faced with inconclusive evidence on cost-effectiveness, policy makers must decide whether there is sufficient evidence to reject or adopt an intervention. If there is insufficient evidence, then either more data should be gathered or policy makers must intervene to improve cost-effectiveness. The NICE Guidance on cochlear implantation (NICE 2009) implements the latter strategy. To increase the likelihood that bilateral implantation is cost-effective, the guidance requires manufacturers of cochlear implants to sell the second electrode array (the implanted part only) for a bilaterally implanted child to the National Health Service at a reduction to the list price of 40%. In our analyses, this reduction improves the average INB while still leaving the likelihood that bilateral implantation is cost-effective at a WTP threshold of £30,000/QALY below the criterion of 0.8.
CONCLUSIONS
Bilateral implantation is possibly a cost-effective use of resources in the National Health Service in the United Kingdom. If society is willing to pay £30,000 to gain a QALY, then bilateral implantation generates a positive net benefit but with a likelihood of being cost-effective Ͻ0.8. Further data on the costs and benefits of bilateral implantation compared with unilateral implantation are required to resolve the uncertainty.
APPENDIX
The questionnaire that was given to respondents included five sections. Section 1 elicited biographical data about the respondent. Each of sections 2 to 5 contained one vignette and elicited TTO and VAS valuations of the quality of life of a child described in that vignette. This Appendix reproduces the introduction to the questionnaire, the four vignettes, and the questions used to elicit VAS and TTO valuations using the child with bilateral implants as an example.
Instructions
We would like you to imagine that you are 33 years old. You have a daughter who is profoundly deaf. You are in a stable relationship with your daughter's mother/father and you are financially secure.
We will now describe four scenarios that relate to your daughter's deafness. Each scenario is followed by two questions. Please start by reading all four of the scenarios. Then, read through each scenario again and answer the two questions that follow it. Please read the scenarios very carefully.
The questions ask about the quality of life of your imaginary daughter. There are no right or wrong answers. We are simply trying to find out how people relate a description of a child to the quality of life that they imagine the child might have.
Scenario No. 1: Your Child Was Born Deaf and Does Not Have a Cochlear Implant or a Hearing Aid
Your child was born profoundly deaf and is now 6 years old. The cause of her deafness is not life threatening, but there is no cure. She has so little hearing that hearing aids cannot help her. She will be unable to hear throughout her life. Physically, however, she is a completely healthy child.
• Your daughter is unable to hear everyday sounds, such as music, voices, and traffic. She cannot hear the sound of her own voice.
• She can understand some of what you say by lipreading, but her main means of communication is sign language. You are taking courses in sign language to communicate with her.
• Your daughter attends a mainstream school, although she spends most of her time in a specialized class for children with impaired hearing, where she works with a small number of other children.
• Your child's ability to use spoken language is progressing at a slower rate than normal. She is finding it difficult to learn to read. You have been advised that she is likely to find reading and writing difficult in the future.
• Socially, she gets on well with other hearing impaired children. She finds it difficult to make friends with children with normal hearing because of problems with communication.
• You worry about your daughter's safety when she is outdoors because she cannot hear warning signals. You feel that you cannot give her as much independence as you would like.
• Your child's deafness sometimes places a strain on your family life because of the level of assistance and attention that she requires.
• You have been advised that it is probable that your daughter will have restricted job opportunities when she is an adult because she will not be able to use the telephone and she will have difficulties in other situations that require spoken communication.
Scenario No. 2: Your Child Was Born Deaf and Has a Cochlear Implant in One Ear
Your child was born profoundly deaf and is now 6 years old. When she was 2 years old, she received a cochlear implant in one ear. (A cochlear implant is an electronic device that is surgically implanted in the inner ear. It helps deaf people to hear by by-passing parts of the ear that are not working and stimulating the nerve of hearing directly with electrical signals.) The operation was a success. There were no complications.
• Your daughter can speak. Everyone can understand what she is saying without much effort.
• She can understand most of what is said to her, especially if she can see the talker's face and lips.
• She finds it difficult to understand speech when there is background noise, even at low levels where you have no difficulty.
• Your daughter's spoken language is developing at the normal rate, but she is a couple of years behind children with normal hearing.
• Your child attends a mainstream school where she is a member of a regular class of children. She receives about 6 hours of help each week during lessons from a learning support assistant. Even so, she is tired at the end of the school day because of the need to concentrate when she listens.
• Your daughter is starting to read and write. She is making progress but she is a bit behind many other members of her class.
• Most of the time, you and your child forget that she has a cochlear implant. However, a blow on the head could damage her implant, so you have to keep an eye on her if she plays rough games.
• You are not too concerned about your daughter's future in terms of academic achievement, employment, and independent living. You have been advised that it is likely that she will live a relatively normal life.
• You have to take a couple of days away from your usual activities each
year for routine hospital appointments to have her implant checked.
• Occasionally, you have to take time away from your usual activities at short notice to attend unforeseen hospital appointments. For example, if your daughter bangs her head or feels sick or dizzy, you need to check with a doctor to find out whether her cochlear implant has been damaged or is causing the symptoms.
• Your child is unable to tell which direction sounds are coming from.
Because of this, she doesn't always know where to look to see who is talking and you worry a little about her safety when she is outdoors.
• You are slightly concerned that the cochlear implant could fail and that another operation would be required to replace it. You have been advised that there is a small possibility that it might not be possible to put a new implant in the same ear. In which case, it would be necessary to implant the other ear. You have been advised that there is a very small possibility that it might not be possible to implant the other ear. If this happened, your daughter would be permanently deaf and unable to use a cochlear implant in either ear.
Scenario No. 3: Your Child Was Born Deaf and Has a Cochlear Implant in One Ear and a Hearing Aid in the Other Ear
Your child was born profoundly deaf and is now 6 years old. When she was 2 years old, she received a cochlear implant in one ear. (A cochlear implant is an electronic device that is implanted surgically in the inner ear. It helps deaf people to hear by by-passing parts of the ear that are not working and stimulating the nerve of hearing directly with electrical signals.) The operation was a success. There were no complications. Your child also uses a hearing aid in her other ear. (A hearing aid is an acoustic device that amplifies sounds. It is fitted without an operation.) The hearing aid enables your child to hear some very low-frequency sounds.
Your daughter has many of the same advantages and disadvantages as were described in the previous scenario (scenario no. 2) with some additional advantages as follows:
• She has grasped the concept of "where" sounds come from. She can tell whether a sound is coming from the left or right, though she finds it difficult to be more accurate than that.
• She can sometimes tell whether a motor vehicle is coming from her left or her right. Also, sometimes she knows where to look to see who is talking.
• As a result, you are a little less worried abut her safety when she is outdoors.
Scenario No. 4: Your Child Has Two Cochlear Implants, One in Each Ear
Your child was born profoundly deaf and is now 6 years old. When she was 2 years old, she received two cochlear implants, one in each ear. (A cochlear implant is an electronic device that is implanted surgically in the inner ear. It helps deaf people to hear by by-passing parts of the ear that are not working and stimulating the nerve of hearing directly with electrical signals.) The operation was a success. There were no complications.
Your daughter has all of the abilities described in scenario no. 2, with some additional advantages as follows:
• She has grasped the idea of "where" sounds come from. She can tell whether sounds come from the left, straight ahead, or the right.
• She can hear speech better in noisy situations because she has the choice of which ear to listen with and can therefore attend with the ear closer to the talker.
• Your daughter can usually tell whether a motor vehicle is coming from her left or her right. As a result, you are less worried about her safety when she is outdoors.
• She can usually understand most of what is said to her, even when she cannot see the talker's face. Also, she usually knows where to look to see who is talking.
• Your child attends a mainstream school and only rarely needs help from a learning support assistant.
• Overall, it is easier for her to listen. As a result, she is less tired at the end of the school day. Questions About Scenario No. 4 Question 1 • To help you express your thoughts about your imaginary child's quality of life, we have drawn a scale. The best quality of life that you can imagine is marked 100, and the worst quality of life that you can imagine is marked 0. We would like you to use the scale to help us understand your thoughts on your imaginary daughter's quality of life.
Please make a mark on the scale to show us how good or bad your daughter's quality of life is with two cochlear implants. You may make the mark anywhere on the scale not just at the points marked by the numbers.
Question 2 • Now we would like you to think about your daughter's quality of life in a different way. Remember, you are 33 years old. Imagine you will live for 50 more years until you are 83 years old. Now, imagine that you could give up some years of your own life in order for your child to have normal hearing. She would have normal hearing for the rest of her life. Imagine that the years you give up would be taken off the end of your life. This question does not measure whether you are a good or bad parent-it is simply a method of obtaining your judgment about how challenging this scenario would be for your daughter.
Please write the number of years that you would give up in this box:
